| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 20, 2005
Accepted on May 18, 2006
From the Twin Research & Genetic Epidemiology Unit (M.d.L., T.A., H.S., T.D.S.), St Thomas’ Hospital, London, UK; Department of Biological Psychology (M.d.L.), Vrije Universiteit, Amsterdam, The Netherlands; Georgia Prevention Institute (H.S., D.G.), Department of Pediatrics, Medical College Georgia, Augusta; and Academic Unit of Molecular Vascular Medicine (T.S.F., K.S., P.J.G., R.A.S.A.), The Leeds Institute for Genetics, Health and Therapeutics, Faculty of Medicine and Health, University of Leeds, UK.
* To whom correspondence should be addressed. E-mail: r.a.s.ariens{at}leeds.ac.uk.
Objective--Activated factor XIII (FXIII) crosslinks fibrin to enhance the mechanical strength of a blood clot and increase its resistance to fibrinolysis. The prevalence of a common variant in the FXIII-A gene (V34L) has been reported to be lower in patients with myocardial infarction and ischemic stroke than in controls, suggesting a protective role for this polymorphism in vascular diseases. The current study investigated 6 single-nucleotide polymorphisms (SNPs) within the FXIII A-subunit gene to locate functional polymorphism(s) responsible for variation in FXIII activation.
Methods and Results--A total of 201 dizygotic twin pairs were genotyped for 1 promoter and all common nonsynonymous coding polymorphisms in the FXIII A-subunit gene: -246G>A, V34L, Y204F, P564L, V650I, and E651Q. Tests of linkage, association, and combined linkage and association were performed using QTDT software. Significant linkage to the V34L polymorphism (P=5x10-12) as well as association (P=3x10-49) was observed. Adjusting for association while performing linkage made the linkage signal disappear for the V34L polymorphism (from
2=47.55, P=5x10-12 to
2=1.30, P=0.25). Only haplotypes containing the 34L allele showed association with FXIII activation.
Conclusion--Testing multiple SNPs in the FXIII A-subunit gene indicates that V34L is the main functional polymorphism influencing FXIII activation.
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |